Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer

Published:2014-10-18 Issue:4 Volume:141 Page:759-765
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Matsuoka Taeko,Kawai Koji,Kimura Tomokazu,Kojima Takahiro,Onozawa Mizuki,Miyazaki Jun,Nishiyama Hiroyuki,Hinotsu Shiro,Akaza Hideyuki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-014-1856-3.pdf

Reference27 articles.

1. Akaza H, Usami M, Hinotsu S et al (2004) Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. Jpn J Clin Oncol 34:329–336

2. Akaza H, Hinotsu S, Usami M et al (2009) Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival. Cancer 115:3437–3445

3. Akaza H, Hinotsu S, Usami M et al (2013) Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score. Prostate Int 1:81–88

4. Albertsen PC, Klotz L, Tombal B et al (2014) Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist. Eur Urol 65:565–573

5. Baade PD, Youlden DR, Cramb SM et al (2013) Epidemiology of prostate cancer in the Asia-Pacific region. Prostate Int 1:47–58

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer;Scientific Reports;2024-01-06

2. Prostate cancer in multi‐ethnic Asian men: Real‐world experience in the Malaysia Prostate Cancer (M‐CaP) Study;Cancer Medicine;2021-10-09

3. Prostate Cancer Registries: Current Status and Future Directions;European Urology;2016-06

4. Experience with Androgen Deprivation Therapy for Prostate Cancer in Japan and Future Perspectives;Current Cancer Drug Targets;2015-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3